Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) Net Income Growth (1y) (2024 - 2026)

Analysis

Grail (GRAL) Net Income Growth (1y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 33.71%
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 12.89%
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 25.51%
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -20.26%
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 120.88%
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 99.11%
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 573.74%
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 3,367.34%
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 36.67%
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn 3.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.28%
Mar 31, 2026 12.26%
Dec 31, 2025 -2.17%
Sep 30, 2025 29.21%
Jun 30, 2025 92.81%
Mar 31, 2025 51.48%
Dec 31, 2024 48.24%
Sep 30, 2024 85.90%
Jun 30, 2024 -721.23%